|
HERA didn't have arms like the US trials: it was the big international trial (Canada, Europe, and beyond I think) that basically randomized to herceptin or no herceptin after any reasonable chemo (so for a lot of women in Europe that would be CMF or just AC without taxol). Interim results were released at ASCO but no subset analysis or anything like that...
Jeff
|